US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Oncotelic Therapeutics

Recent news which mentions Oncotelic Therapeutics

Biotech Takes Innovative Approach To Raising Capital For Its Promising Anti-Cancer Drug
Tags Benzinga General Benzinga All Access
From Benzinga
Oncotelic Therapeutics' (OTCQB: OTLC) Lead Immunotherapy Candidate For Treating Deadly Cancers, OT-101, Could Hold Potential Applications In Multiple Multi-Billion Dollar Markets
Tickers MRK OTLC
Tags Penny Stocks Market News Biotech
From Benzinga
With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers
Tickers MRK OTLC
Tags Market News Penny Stocks Biotech
From Benzinga
The Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB:OTLC) Is Leading The Charge
Tickers OTLC
Tags Biotech Penny Stocks Market News
From Benzinga
The Solid Tumors Market Is Expected To Be Worth $901.27 Billion By 2029, And Oncotelic Therapeutics (OTCQB: OTLC) Is Helping Lead The Charge
Tickers OTLC
Tags Oncotelic Therapeutics General Movers & Shakers
From Benzinga